Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy
Author:
Affiliation:
1. Department of Urology; Chiba University Graduate School of Medicine; Chiba Japan
2. Department of Urology; Japan Community Healthcare Organization Tokyo Shinjuku Medical Center; Tokyo Japan
Funder
Chiba University
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/iju.13521/fullpdf
Reference24 articles.
1. Editorial Comment to Androgen receptor targeted therapies in castration-resistant prostate cancer: Bench to clinic;Sakamoto;Int. J. Urol.,2016
2. Editorial Comment to Androgen receptor splice variant 7 in castration-resistant prostate cancer: clinical considerations;Sakamoto;Int. J. Urol.,2016
3. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D'Amico;JAMA,2008
4. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial;Denham;Lancet Oncol.,2011
5. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N. Engl. J. Med.,2011
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pituitary-testis axis dysfunction following adjuvant androgen deprivation therapy;Endocrine-Related Cancer;2023-01-01
2. Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Enzalutamide;The Korean Journal of Urological Oncology;2021-02-28
3. Long-term Castration-related Outcomes in Patients With High-risk Localized Prostate Cancer Treated With Androgen Deprivation Therapy With or Without Docetaxel and Estramustine in the UNICANCER GETUG-12 Trial;Clinical Genitourinary Cancer;2020-12
4. Higher serum testosterone levels predict poor prognosis in castration‐resistant prostate cancer patients treated with docetaxel;The Prostate;2019-12-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3